Abstract
The present study was undertaken to evaluate the diagnostic approaches, treatment results and failure patterns of lymphoepithelial carcinoma of the major salivary gland (LECSG). Patients were treated by definitive surgical resection and postoperative radiotherapy in an attempt to identify the proper strategies for the management of this disease. Patients with a histological diagnosis of primary lymphoepithelial carcinoma in the major salivary gland that was treated at our institution between January 2005 and December 2011 were comprehensively analyzed. An en bloc radical excision, which generally removes the salivary gland with level II and Ib lymph nodes, followed by postoperative radiotherapy was the standard treatment for this group of patients. Radical neck dissection was only performed in patients with metastatic lymphadenopathy. Postoperative irradiation was delivered to the tumor bed and involved nodes at a dose of 60 Gy and to the ipsilateral cervical lymph nodes at a dose of 56 Gy. Clinical and pathological factors correlated with locoregional control (LRC), progression-free survival (PFS) and overall survival (OS) were analyzed using the log-rank test and a Cox proportional hazards model. A total of 37 patients with a median age of 45 years were enrolled in this study. The study population consisted of 21 males and 16 females. There were seven patients with stage I disease, 10 patients with stage II disease, nine patients with stage III disease and 11 patients with stage IV disease. With a median follow-up of 39 months (range 12–90 months), the 3-year LRC, PFS and OS were 94.3, 91.6, and 92.9 %, respectively. Only two patients died of local–regional recurrences and distant metastases. No statistically significant prognostic predictors of LRC, PFS and OS were found. The presence of positive cervical lymph nodes showed a trend toward poorer outcome. Surgical resection with postoperative radiotherapy is a reasonable and proper treatment approach in the definitive management of LECSG and results in a favorable prognosis for a significant proportion of patients. No clinicopathological or therapeutic features were found to be suitable predictive factors for prognosis; thus, disease progression should be carefully monitored, especially for those patients with cervical node involvement.
Similar content being viewed by others
References
Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein–Barr virus and Kaposi’s sarcoma herpesvirus/human herpesvirus 8. Lyon, France, 17–24 June 1997.
Tang CG, Schmidtknecht TM, Tang GY, Schloegel LJ, Rasgon B. Lymphoepithelial carcinoma: a case of a rare parotid gland tumor. Perm J. 2012;16(3):60–2.
Schneider M, Rizzardi C. Lymphoepithelial carcinoma of the parotid glands and its relationship with benign lymphoepithelial lesions. Arch Pathol Lab Med. 2008;132(2):278–82.
Saqui-Salces M, Martinez-Benitez B, Gamboa-Dominguez A. EBV+ lymphoepithelial carcinoma of the parotid gland in Mexican Mestizo patients with chronic autoimmune diseases. Pathol Oncol Res. 2006;12(1):41–5.
Manganaris A, Patakiouta F, Xirou P, Manganaris T. Lymphoepithelial carcinoma of the parotid gland: is an association with Epstein–Barr virus possible in non-endemic areas? Int J Oral Maxillofac Surg. 2007;36(6):556–9.
Saemundsen AK, Albeck H, Hansen JP, et al. Epstein–Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes. Br J Cancer. 1982;46(5):721–8.
Hilderman WC, Gordon JS, Large HL Jr, Carroll CF Jr. Malignant lymphoepithelial lesion with carcinomatous component apparently arising in parotid gland. A malignant counterpart of benign lymphoepithelial lesion? Cancer. 1962;15:606–10.
Hamilton-Dutoit SJ, Therkildsen MH, Neilsen NH, Jensen H, Hansen JP, Pallesen G. Undifferentiated carcinoma of the salivary gland in Greenlandic Eskimos: demonstration of Epstein–Barr virus DNA by in situ nucleic acid hybridization. Hum Pathol. 1991;22(8):811–5.
Huang DP, Ng HK, Ho YH, Chan KM. Epstein–Barr virus (EBV)-associated undifferentiated carcinoma of the parotid gland. Histopathology. 1988;13(5):509–17.
Chan JK, Yip TT, Tsang WY, Poon YF, Wong CS, Ma VW. Specific association of Epstein–Barr virus with lymphoepithelial carcinoma among tumors and tumorlike lesions of the salivary gland. Arch Pathol Lab Med. 1994;118(10):994–7.
Saku T, Cheng J, Jen KY, et al. Epstein–Barr virus infected lymphoepithelial carcinomas of the salivary gland in the Russia–Asia area: a clinicopathologic study of 160 cases. Arkh Patol. 2003;65(2):35–9.
Nagao T, Ishida Y, Sugano I, et al. Epstein–Barr virus-associated undifferentiated carcinoma with lymphoid stroma of the salivary gland in Japanese patients. Comparison with benign lymphoepithelial lesion. Cancer. 1996;78(4):695–703.
Kuo T, Hsueh C. Lymphoepithelioma-like salivary gland carcinoma in Taiwan: a clinicopathological study of nine cases demonstrating a strong association with Epstein–Barr virus. Histopathology. 1997;31(1):75–82.
Tsai CC, Chen CL, Hsu HC. Expression of Epstein–Barr virus in carcinomas of major salivary glands: a strong association with lymphoepithelioma-like carcinoma. Hum Pathol. 1996;27(3):258–62.
Wang CP, Chang YL, Ko JY, Lou PJ, Yeh CF, Sheen TS. Lymphoepithelial carcinoma versus large cell undifferentiated carcinoma of the major salivary glands. Cancer. 2004;101(9):2020–7.
Abdelkrim SB, Trabelsi A, Hammedi F, et al. Primary lymphoepithelial carcinoma of the parotid gland in a North African woman. Rare tumors. 2009;1(1):e16.
Lu BJ, Zhu J, Gao L, Xie L, Xu JY, Lai MD. Diagnostic accuracy and pitfalls in fine needle aspiration cytology of salivary glands: a study of 113 cases. Zhonghua Bing Li Xue Za Zhi. 2005;34(11):706–10.
Seethala RR, LiVolsi VA, Baloch ZW. Relative accuracy of fine-needle aspiration and frozen section in the diagnosis of lesions of the parotid gland. Head Neck. 2005;27(3):217–23.
Lanier AP, Clift SR, Bornkamm G, Henle W, Goepfert H, Raab-Traub N. Epstein–Barr virus and malignant lymphoepithelial lesions of the salivary gland. Arctic Med Res. 1991;50(2):55–61.
Saw D, Lau WH, Ho JH, Chan JK, Ng CS. Malignant lymphoepithelial lesion of the salivary gland. Hum Pathol. 1986;17(9):914–23.
Tsang WYW, Kuo TT, Chan JKC. Lymphoepithelial carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005. p. 251–2.
Abdulla AK, Mian MY. Lymphoepithelial carcinoma of salivary glands. Head Neck. 1996;18(6):577–81.
Hsu YC, Lu HF, Huang CC, Hsu RF, Su CY. Malignant lymphoepithelial lesions of the salivary gland. Otolaryngol Head Neck Surg. 2006;134(4):661–6.
Teo PM, Chan AT, Lee WY, Leung SF, Chan ES, Mok CO. Failure patterns and factors affecting prognosis of salivary gland carcinoma: retrospective study. Hong Kong Med J. 2000;6(1):29–36.
Dubey P, Ha CS, Ang KK, et al. Nonnasopharyngeal lymphoepithelioma of the head and neck. Cancer. 1998;82(8):1556–62.
Sheen TS, Tsai CC, Ko JY, Chang YL, Hsu MM. Undifferentiated carcinoma of the major salivary glands. Cancer. 1997;80(3):357–63.
Myers JN, Peel RL, Myers EN. Pathologic quiz case 1 Malignant lymphoepithelial lesion of the parotid gland. Arch Otolaryngol Head Neck Surg. 1995;121(4):479–82.
Zhang Q, Qing J, Wei MW, Guo ZM. Clinical analysis of sixteen cases of lymphoepithelial carcinoma of salivary gland. Ai Zheng. 2005;24(11):1384–7.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, F., Zhu, G., Wang, Y. et al. A clinical analysis of 37 cases with lymphoepithelial carcinoma of the major salivary gland treated by surgical resection and postoperative radiotherapy: a single institution study. Med Oncol 31, 957 (2014). https://doi.org/10.1007/s12032-014-0957-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-014-0957-9